Related Articles
Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells
Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells
Selective leukemia cell death by activation of the double-stranded RNA-dependent protein kinase PKR